Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)

INTRODUCTION: Combination therapy with both basal insulin (BI) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is an effective treatment in patients with uncontrolled type 2 diabetes mellitus (T2DM). The recent development and release of a fixed-ratio combination of slow-release insulin deg...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diabetes Ther
Huvudupphovsmän: Zenari, Luciano, Da Porto, Andrea, De Moliner, Lorena, Lugli, Francesca, Guazzoni, Valeria, Groppelli, Gloria, Molteni, Laura, Bracaccia, Massimo, Frison, Vera, Simioni, Natalino, Bonsembiante, Barbara, Miranda, Cesare, Lapolla, Annunziata
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Healthcare 2020
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7843811/
https://ncbi.nlm.nih.gov/pubmed/33104959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00945-4
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk